Pediatr Emerg Med J.  2024 Oct;11(4):191-195. 10.22470/pemj.2024.01039.

Successful use of ketamine in reversing the paradoxical reactions to midazolam after failing flumazenil

• Aldosari AN
• Alnashi S

• KMID: 2559553
• DOI: http://doi.org/10.22470/pemj.2024.01039

Abstract

Midazolam is generally effective and safe to be widely used in the management of seizures, procedural sedation, and anxiolytic. However, paradoxical reactions, though rare, present clinical challenges. Flumazenil is the preferred option for reversing the reactions. Additionally, ketamine, physostigmine, and haloperidol have been successfully used to counteract the adverse effects (AEs). Herein, we report an 11-year-old girl with epilepsy who was brought to the emergency department with a breakthrough seizure. Approximately 10 minutes after a midazolam administration, she developed increased agitation, confusion, uncontrollable crying, and excessive random movements. Despite receiving 4 doses of flumazenil, no improvement was observed. However, the AEs ceased following the administration of ketamine. This report may increase awareness of the uncommon AEs and equip clinicians to effectively handle such occurrences.

Keyword

Benzodiazepines; Drug-Related Side Effects and Adverse Reactions; Flumazenil; Ketamine; Midazolam

Reference

References

1. Lingamchetty TN, Hosseini SA, Saadabadi A. Midazolam [updated 2023 Jun 5]. In: StatPearls [Internet]. StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537321/.

2. Moon YE. Paradoxical reaction to midazolam in children. Korean J Anesthesiol. 2013; 65:2–3.

3. Sharbaf Shoar N, Bistas KG, Saadabadi A. Flumazenil [updated 2023 May 23]. In: StatPearls [Internet]. StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470180/.

4. Golparvar M, Saghaei M, Sajedi P, Razavi SS. Paradoxical reaction following intravenous midazolam premedication in pediatric patients - a randomized placebo controlled trial of ketamine for rapid tranquilization. Paediatr Anaesth. 2004; 14:924–30.

5. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004; 24:1177–85.

6. Gupta MK, Mondkar JA, Hegde D. Paradoxical reaction to midazolam in preterm neonates: a case series. Indian J Crit Care Med. 2018; 22:300–2.

7. Shin YH, Kim MH, Lee JJ, Choi SJ, Gwak MS, Lee AR, et al. The effect of midazolam dose and age on the paradoxical midazolam reaction in Korean pediatric patients. Korean J Anesthesiol. 2013; 65:9–13.

8. Benson JA, Löw K, Keist R, Mohler H, Rudolph U. Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits. FEBS Lett. 1998; 431:400–4.

9. Short TG, Forrest P, Galletly DC. Paradoxical reactions to benzodiazepines–a genetically determined phenomenon? Anaesth Intensive Care. 1987; 15:330–1.

10. Johnson TN, Tanner MS, Taylor CJ, Tucker GT. Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol. 2001; 51:451–60.

11. van der Bijl P, Roelofse JA. Disinhibitory reactions to benzodiazepines: a review. J Oral Maxillofac Surg. 1991; 49:519–23.

12. Weinbroum AA, Szold O, Ogorek D, Flaishon R. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol. 2001; 18:789–97.

13. Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 1997; 86:903–17.